Teladoc Health, Inc. — Form 10-Q
Filed July 30, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
Charles Divita, III, CEO and Principal Financial Officer, certified Teladoc's Q2 2026 10-Q (period ended June 30, 2026) on July 30, 2026. The certification confirms financial statements fairly present the company's financial condition and results of operations, disclosure controls and procedures are effective, and no material weaknesses in internal control over financial reporting were identified. No specific financial metrics, counterparties, transactions, or operational changes are detailed in these certification exhibits.
Why this rating
Routine SOX officer certification exhibits; no new business developments, transactions, or material changes disclosed. Standard quarterly compliance filing.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.